Relationships of advanced glycation end products and oxidized low-density lipoprotein in elderly diabetic patients with osteoporosis

doi:10.3969/j.issn.1673-8640.2016.010.010

Abstract

Abstract:

Objective To investigate the relationships of advanced glycation end products（AGE） and oxidized low-density lipoprotein（ox-LDL） in elderly diabetic patients with osteoporosis（OP）. Methods A total of 304 patients with type 2 diabetes mellitus（T2DM）were enrolled,and their ages were ≥60 years. According to the occurrence of OP,they were classified into simple T2DM group（201 cases） and T2DM with OP group（103 cases）. A total of 68 healthy subjects were enrolled as healthy control group. The bone mineral densities of lumbar spine（L1-L4）,spine（except lumbar spine）,left femoral neck（Neck）,left femoral large rotor（Troch） and Ward's triangle area were determined. AGE,ox-LDL,glycated hemoglobin A_1c（HbA_1c）,calcium（Ca）,phosphorus（P）,creatinine（Cr）,urea,fasting plasma glucose（FPG）,2 h postprandial plasma glucose（2 hPG）,uric acid（UA）/ Cr and alkaline phosphatase（ALP） were determined. The data of sex,age,the use of hypoglycemic drugs,the histories of smoking and hypertension,body mass index（BMI） were recorded. Multivariate Logistic regression analysis was used to evaluate the risk factors for T2DM with OP. Spearman correlation analysis was used to analyze the relationship of bone mineral densities with AGE and ox-LDL in T2DM with OP group. Receiver operating characteristic（ROC） curve was used to evaluate the sensitivities and specificities of ox-LDL and AGE for the diagnosis of T2DM with OP.Results HbA_1c,Cr,UA/Cr,FPG,ALP,AGE,ox-LDL and the proportion of hypertension in simple T2DM and T2DM with OP groups were higher than those in healthy control group（P<0.05）. UA/Cr ,AGE and ox-LDL in T2DM with OP group were higher than those in simple T2DM group（P<0.05）,and there was no statistical significance for the other indices（P>0.05）. The bone mineral densities of lumbar spine（L1-L4）,spine,Neck,Troch and Ward's triangle area in T2DM with OP group were lower than those in simple T2DM group（P<0.05）,and the bone mineral densities of lumbar spine（L1-L4）and spine in T2DM with OP group and simple T2DM group were lower than those in healthy control group（P<0.05）. Logistic regression analysis showed that the history of hypertension,UA/Cr,HbA_1c,AGE and ox-LDL were risk factors for T2DM with OP. Spearman correlation analysis showed that AGE and ox-LDL had correlations with the bone mineral densities of Neck,Troch and Wald's triangle area（P<0.05）and no correlation with those of lumbar spine（L1-L4） and spine（P>0.05）. ROC curve showed that the sensitivity,specificity and area under ROC curve of the combined determination of ox-LDL and AGE were higher than those of ox-LDL and AGE single determinations（P<0.05）. Conclusions AGE and ox-LDL have correlations with the incidence of T2DM with OP,and the combined determination of AGE and ox-LDL can improve efficacy for the diagnosis of T2DM with OP.

Key words: Advanced glycation end products, Oxidized low-density lipoprotein, Correlation, Diabetes mellitus, Osteoporosis, Elderly

CLC Number:

R446.1

JIANG Fan, CHEN Xiaozhuang, ZHOU Xiaoli, TONG Shan. Relationships of advanced glycation end products and oxidized low-density lipoprotein in elderly diabetic patients with osteoporosis[J]. Laboratory Medicine, 2016, 31(10): 883-888.

Figures/Tables 6

References 17

[1]	MATHEN PG,THABAH MM,ZACHARIAH B,et al. Decreased bone mineral density at the femoral neck and lumbar spine in South Indian patients with type 2 diabetes[J]. J Clin Diagn Res,2015,9(9):OC8-OC12.
[2]	KUMEDA Y.Osteoporosis in diabetes[J]. Clin Calcium,2008,18(5):589-599.
[3]	童明宏,肖国平,丁慧. 骨质疏松症与骨转换标志物的相关性研究[J]. 检验医学,2013,28(2):111-113.
[4]	亚太地区2型糖尿病政策组. 2型糖尿病使用目标和处理[S]. 1999.
[5]	张智海,刘忠厚,李娜,等. 中国人骨质疏松症诊断标准专家共识(第三稿2014版)[J]. 中国骨质疏松杂志,2014,20(9):1007-1010.
[6]	American Diabetes Association.Diagnosis and classification of diabetes mellitus[J]. Diabetes Care,2012,35(Suppl 1):S64-S71.
[7]	BILEZIKIAN JP,WATTS NB,USISKIN K,et al.Evaluation of bone mineral density and bone biomarkers in patients with type 2 diabetes treated with canagliflozin[J]. J Clin Endocrinol Metab,2016,101(1):44-51.
[8]	范光磊,薄静莉,陈杰敏,等. 骨转换生化标志物与老年2型糖尿病患者并发骨质疏松的相关性研究[J]. 中华老年医学杂志,2012,31(8):657-661.
[9]	郑和昕,江缨,黄虹,等. 老年男性2型糖尿病并存骨质疏松症患者血浆脑钠肽的变化[J]. 中华老年医学杂志,2013,32(3):263-267.
[10]	王峥嵘,朱昀. 老年慢性疾病患者骨质疏松的相关因素分析[J]. 中华老年医学杂志,2014,33(3):272-275.
[11]	MONTAGNANI A,GONNELLI S,ALESSANDRI M,et al.Osteoporosis and risk of fracture in patients with diabetes:an update[J]. Aging Clin Exp Res,2011,23(2):84-90.
[12]	OGATA M,IDE R,TAKIZAWA M,et al.Association between basal metabolic function and bone metabolism in postmenopausal women with type 2 diabetes[J]. Nutrition,2015,31(11-12):1394-1401.
[13]	何文军,黄家平,梁伟东,等. 氧化低密度脂蛋白和 C 反应蛋白与冠状动脉支架置入术后再狭窄的关系研究[J]. 检验医学,2015,30(5):484-488.
[14]	ALSELAMI NM,NOURELDEEN AF,AL-GHAMDI MA,et al.Bone turnover biomarkers in obese postmenopausal Saudi women with type-Ⅱ diabetes mellitus[J].Afr Health Sci,2015,15(1):90-96.
[15]	蒋兰兰,朱剑,吴锦丹,等. 绝经后2 型糖尿病患者不同部位骨密度的变化情况及影响因素[J]. 中国骨质疏松杂志,2012,18(3):229-233.
[16]	NEGLIA C,AGNELLO N,ARGENTIERO A,et al.Increased risk of osteoporosis in postmenopausal women with type 2 diabetes mellitus:a three-year longitudinal study with phalangeal QUS measurements[J]. J Biol Regul Homeost Agents, 2014, 28(4):733-741.
[17]	SHAN PF,WU XP,ZHANG H,et al.Age-related bone mineral density,osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus[J]. J Endocrinol Invest,2011,34(3):190-196.

组别	例数	性别		HbA_1c（%）	Cr（μmol/L）	尿素（mmol/L）
组别	例数	男（例）	女（例）	HbA_1c（%）	Cr（μmol/L）	尿素（mmol/L）
正常对照组	68	30	38	5.64±1.93	54.78±10.23	5.35±0.97
单纯T2DM组	201	100	101	8.17±2.03^*	67.90±9.98^*	5.67±1.08
T2DM合并OP组	103	47	56	9.11±2.65^*	69.21±10.34^*	5.49±1.33
组别	UA/Cr比值（mg/g）	Ca（mmol/L）		P（mmol/L）	FPG（mmol/L）	ALP（U/L）
正常对照组	11.56±4.92	2.45±0.47		1.23±0.21	5.49±2.03	45.11±6.78
单纯T2DM组	19.78±11.79	2.43±0.46		1.19±0.19	10.17±2.49^*	62.73±8.71^*
T2DM合并OP组	85.43±34.67	2.44±0.40		1.18±0.20	11.16±2.60^*	63.47±8.25^*
组别	BMI（kg/m²）	AGEs（ng/L）		ox-LDL（μg/L）	吸烟史[例（%）]	高血压史[例（%）]
正常对照组	22.31±4.68	36.97±7.55		249.86±46.66	21（30.88）	7（10.29）
单纯T2DM组	25.45±5.17	58.11±11.39^*		399.95±60.43^*	70（34.83）	101（50.25）^*
T2DM合并OP组	24.86±5.26	87.19±14.84^*#		518.86±81.76^*#	47（45.63）	65（63.11）^*

组别	例数	性别		HbA_1c（%）	Cr（μmol/L）	尿素（mmol/L）
组别	例数	男（例）	女（例）	HbA_1c（%）	Cr（μmol/L）	尿素（mmol/L）
正常对照组	68	30	38	5.64±1.93	54.78±10.23	5.35±0.97
单纯T2DM组	201	100	101	8.17±2.03^*	67.90±9.98^*	5.67±1.08
T2DM合并OP组	103	47	56	9.11±2.65^*	69.21±10.34^*	5.49±1.33
组别	UA/Cr比值（mg/g）	Ca（mmol/L）		P（mmol/L）	FPG（mmol/L）	ALP（U/L）
正常对照组	11.56±4.92	2.45±0.47		1.23±0.21	5.49±2.03	45.11±6.78
单纯T2DM组	19.78±11.79	2.43±0.46		1.19±0.19	10.17±2.49^*	62.73±8.71^*
T2DM合并OP组	85.43±34.67	2.44±0.40		1.18±0.20	11.16±2.60^*	63.47±8.25^*
组别	BMI（kg/m²）	AGEs（ng/L）		ox-LDL（μg/L）	吸烟史[例（%）]	高血压史[例（%）]
正常对照组	22.31±4.68	36.97±7.55		249.86±46.66	21（30.88）	7（10.29）
单纯T2DM组	25.45±5.17	58.11±11.39^*		399.95±60.43^*	70（34.83）	101（50.25）^*
T2DM合并OP组	24.86±5.26	87.19±14.84^*#		518.86±81.76^*#	47（45.63）	65（63.11）^*

组别	例数	腰椎
组别	例数	L1	L2	L3	L4
正常对照组	68	0.87±0.14	0.94±0.19	0.99±0.17	1.05±0.19
单纯T2DM组	201	0.76±0.11^*	0.80±0.16^*	0.84±0.15^*	0.86±0.17^*
T2DM合并OP组	103	0.64±0.09^*#	0.66±0.10^*#	0.69±0.11^*#	0.71±0.13^*#

组别	脊柱	Neck	Troch	Wald's三角区
正常对照组	0.98±0.17	0.80±0.13	0.65±0.11	0.59±0.14
单纯T2DM组	0.76±0.15^*	0.74±0.11	0.62±0.12	0.55±0.15
T2DM合并OP组	0.63±0.10^*#	0.63±0.10^*#	0.45±0.09^*#	0.39±0.09^*#

组别	例数	腰椎
组别	例数	L1	L2	L3	L4
正常对照组	68	0.87±0.14	0.94±0.19	0.99±0.17	1.05±0.19
单纯T2DM组	201	0.76±0.11^*	0.80±0.16^*	0.84±0.15^*	0.86±0.17^*
T2DM合并OP组	103	0.64±0.09^*#	0.66±0.10^*#	0.69±0.11^*#	0.71±0.13^*#